无创可视分子成像技术在支气管哮喘气道炎症评估中的研究进展  

Research progress of noninvasive molecular imaging in evaluation of airway inflammation in bronchial asthma

作　　者：郑禾[1] 罗凤鸣[1] 王发平[1] 卢海燕[1] Zheng He;Luo Fengming;Wang Faping;Lu Haiyan(Department of Respiratory and Critical Care Medicine,West China Hospital,Sichuan University,Chengdu 610041,China)

机构地区：[1]四川大学华西医院呼吸与危重症医学科,成都610041

出　　处：《国际呼吸杂志》2019年第22期1751-1755,共5页International Journal of Respiration

基　　金：国家自然科学基金项目(81470268)。

摘　　要：支气管哮喘是一种以不同程度的支气管阻塞、气道高反应性和黏液分泌增加为特点的慢性非特异性气道炎症性疾病。评估气道炎症对判断病情及指导治疗以及判断预后具有重要意义。无创可视分子成像是一种新型的无创、实时监测气道炎症的成像方式,探索其对支气管哮喘评估价值显得意义重大。Bronchial asthma is a chronic non-specific airway inflammatory disease characterized by varying degrees of bronchial obstruction,airway hyperresponsiveness,and increased mucus secretion.Assessing airway inflammation is important for judging the condition and guiding treatment and prognosis.Non-invasive visual molecular imaging is a new type of non-invasive,real-time monitoring of airway inflammation imaging,and its significance in assessing bronchial asthma is significant.

关 键 词：哮喘 分子成像 生物标记物 研究进展 

分 类 号：R56[医药卫生—呼吸系统]